Biotech Business - June 25, 2020
Camurus announces stronger than expected sales during the first half of 2020
Camurus has announced revised full year 2020 guidance for the company’s revenue and product sales. Camurus’ guidance for net revenue is increased to SEK 340–380 million from SEK 290–330 million with estimated product sales of SEK 310–340 million, previously SEK 240–280 million. The improvements are driven by increasing market shares of Buvidal for treatment of […]
Financing - June 17, 2020
Atrogi raises 90 million SEK in a completed rights issue
Swedish diabetes company Atrogi has recently completed a rights issue, and among the anchor investors is South Korea’s largest venture capital company Korea Investment Partners (KIP). “We see the investment by such a strong and experienced player as KIP as powerful confirmation of our groundbreaking research and the market potential for the drug we are […]
Financing - June 16, 2020
New report: 35 billion SEK to Swedish life sciences in the past 5 years
The period 2015-2019 has been a busy, and expansive one for Swedish life science companies, according to data analysed by Industrifonden. Industrifonden’s just-released Life Science Report, based on fresh data and analysis examines the flows of capital to Therapeutics, Healthtech, Diagnostics, and Medtech companies from 2015 to 2019. Of the 35 billion SEK total, the […]
Financing - June 16, 2020
Zelluna Immunotherapy raises 7.5 million EUR
Zelluna Immunotherapy has announced the completion of a fundraise to fully focus on the development of its TCR guided Natural Killer (NK) cell therapy platform (TCR-NK) for the treatment of cancers. A total of approximately EUR 7.5 million has been raised in equity financing and public grants. Zelluna’s strategy is to concentrate on the development […]
Biotech Business - June 11, 2020
BioInvent completes directed share issue of 487 million SEK
The Board of Directors of BioInvent International has resolved to issue a directed share issue to Swedish and international institutional investors. Investors in the Directed Share Issue are a number of Swedish and international investors, including new investors such as HBM Healthcare Investments Ltd. (“HBM), Swedbank Robur Medica and Invus Public Equities, L.P. as well […]
Financing - June 10, 2020
HiloProbe attracts millions in new investment
HiloProbe has attracted new investment capital after developing a diagnostic and prognostic product for colon and rectal cancer. HiloProbe has developed a product called ColoNode that is used for the diagnosis and prognosis of colon and rectal cancer by identifying tumor cells in lymph nodes and measuring their aggressiveness. This analysis is performed following surgery […]
